Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

I. Margineanu · SciRah

Researcher profile · Semantic Scholar

I. Margineanu

Share profile

I. Margineanu — researcher profile on SciRah

h-index: 8
Works: 18
Citations: 277

Most-cited papers

Clinical standards for the dosing and management of TB drugs
J. Alffenaar, S. Stocker, L. D. Forsman, A. Garcia-Prats +47 more
2022The International Journal of Tuberculosis and Lung Disease64 citations Open access
Semantic Scholar
Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis
K. Rustage, Jessica Lobe, S. Hayward, K. Kristensen +10 more
2021medRxiv55 citations Open access
Semantic Scholar
Clinical standards for the management of adverse effects during treatment for TB
K. P. Singh, A. Carvalho, R. Centis, L. D. Ambrosio +61 more
2023The International Journal of Tuberculosis and Lung Disease49 citations Open access
Semantic Scholar
Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs.
Johanna Kuhlin, M. Sturkenboom, S. Ghimire, I. Margineanu +8 more
2019Clinical Mass Spectrometry29 citations Open access
Semantic Scholar
Practices of therapeutic drug monitoring in tuberculosis: an international survey
I. Margineanu, O. Akkerman, D. Cattaneo, D. Goletti +6 more
2022European Respiratory Journal22 citations Open access
Semantic Scholar
eHealth in TB clinical management
I. Margineanu, C. Louka, O. Akkerman, Y. Stienstra +1 more
2022The International Journal of Tuberculosis and Lung Disease15 citations Open access
Semantic Scholar
Specificity of anti-albumin autoantibodies in liver diseases.
D. Onicǎ, I. Margineanu, R. Lenkei
1981Molecular Immunology9 citations
Semantic Scholar
Country-specific approaches to latent tuberculosis screening targeting migrants in EU/EEA* countries: A survey of national experts, September 2019 to February 2020
I. Margineanu, K. Rustage, T. Noori, Dominik Zenner +8 more
2022Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin8 citations Open access
Semantic Scholar
Patients and Medical Staff Attitudes Toward the Future Inclusion of eHealth in Tuberculosis Management: Perspectives From Six Countries Evaluated using a Qualitative Framework
I. Margineanu, C. Louka, M. Vincenti-González, A. Saktiawati +6 more
2020JMIR mHealth and uHealth8 citations Open access
Semantic Scholar
Immunochemical characterization of anti-albumin antibodies in liver diseases.
D. Onicǎ, A. Călugăru, I. Margineanu, G. Zamfir +1 more
1983Clinical Immunology and Immunopathology8 citations
Semantic Scholar
Asthma-like symptoms in a patient with rheumatoid arthritis and Adalimumab treatment.
I. Margineanu, R. Crisan, T. Mihăescu
2015Pneumologia5 citations
Semantic Scholar
TB therapeutic drug monitoring – analysis of opportunities in Romania and Ukraine
I. Margineanu, T. Butnaru, F. Gafar, D. Băiceanu +10 more
2023The International Journal of Tuberculosis and Lung Disease4 citations Open access
Semantic Scholar
Prospects for the use of artificial intelligence to predict the spread of tuberculosis infection in the WHO European Region
L. Todoriko, Оксана Анатоліївна Андрієць, Y. Vyklyuk, I. Semyaniv +4 more
2023Tuberculosis Lung Diseases HIV Infection1 citations Open access
Semantic Scholar
Corrigendum to “Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs” [Clin. Mass Spectrom. 14(Part A) (2019) 34–45]
Johanna Kuhlin, M. Sturkenboom, S. Ghimire, I. Margineanu +8 more
2022Journal of Mass Spectrometry and Advances in the Clinical Lab1 citations Open access
Semantic Scholar
TB and COVID-19 in migrants - the need to focus on both conditions.
I. Margineanu, Z. Mor, D. Garcia, C. Gilpin +3 more
2021The International Journal of Tuberculosis and Lung Disease1 citations Open access
Semantic Scholar
Factors influencing drug susceptible tuberculosis outcomes in Eastern Europe
L. Todoriko, I. Margineanu, I. Semianiv, F. Gafar +8 more
2022Tuberculosis Lung Diseases HIV Infection0 citations Open access
Semantic Scholar
Patients and Medical Staff Attitudes Toward the Future Inclusion of eHealth in Tuberculosis Management: Perspectives From Six Countries Evaluated using a Qualitative Framework (Preprint)
I. Margineanu, C. Louka, M. Vincenti-González, A. Saktiawati +6 more
20200 citations Open access
Semantic Scholar
Trials of Nilverm (tetramisole) in some helminthiases of ruminants.
D. Negru, I. Didă, S. Popescu, I. Gheorghiu +2 more
19700 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

O. Akkerman×10
Invite
O. Akkerman — researcher profile on SciRah
Y. Stienstra×6
Invite
Y. Stienstra — researcher profile on SciRah
J. Alffenaar×4
Invite
J. Alffenaar — researcher profile on SciRah
D. Goletti×3
Invite
D. Goletti — researcher profile on SciRah

×3

Invite

J. Bruchfeld — researcher profile on SciRah

A. Saktiawati×3

Invite

A. Saktiawati — researcher profile on SciRah

M. Sturkenboom×3

Invite

M. Sturkenboom — researcher profile on SciRah

Invite

C. Louka — researcher profile on SciRah

J. Alffenaar×3

Invite

J. Alffenaar — researcher profile on SciRah

Invite

S. Stocker — researcher profile on SciRah

L. D. Forsman×2

Invite

L. D. Forsman — researcher profile on SciRah

A. Garcia-Prats×2

Invite

A. Garcia-Prats — researcher profile on SciRah